We are live on ! Find out more
GRTS

Gritstone bio, Inc. Common Stock

Delisted

GRTS was delisted on the 21st of October, 2024.

6 hedge funds and large institutions have $773 invested in Gritstone bio, Inc. Common Stock in 2024 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 50 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

89% less funds holding

Funds holding: 566 (-50)

98% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 50

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

100% less capital invested

Capital invested by funds: $20.7M → $773 (-$20.7M)

Holders
6
Holders Change
-50
Holders Change %
-89.29%
% of All Funds
0.08%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
1
Increased
1
Reduced
2
Closed
50
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
XT
26
XTX Topco
Cayman Islands
-$45K -77,545 Closed
PAS
27
Point72 Asia (Singapore)
Singapore
-$43.7K -75,434 Closed
Charles Schwab
28
Charles Schwab
California
-$38.6K -66,565 Closed
TPWA
29
Twin Peaks Wealth Advisors
California
-$29.5K -50,811 Closed
Bank of America
30
Bank of America
North Carolina
-$24.2K -41,836 Closed
CAPTRUST Financial Advisors
31
CAPTRUST Financial Advisors
North Carolina
-$21.2K -36,600 Closed
KWM
32
Kingsview Wealth Management
Oregon
-$20.3K -35,000 Closed
Wells Fargo
33
Wells Fargo
California
-$17K -29,251 Closed
Creative Planning
34
Creative Planning
Kansas
-$14.4K -24,910 Closed
VF
35
Virtu Financial
New York
-$13K -23,172 Closed
CFM
36
Catalyst Funds Management
Australia
-$13.4K -23,100 Closed
Qube Research & Technologies (QRT)
37
Qube Research & Technologies (QRT)
United Kingdom
-$12.5K -21,600 Closed
FWM
38
Fairhaven Wealth Management
Illinois
-$12K -20,619 Closed
VPIM
39
Vanguard Personalized Indexing Management
California
-$11K -19,041 Closed
EGM
40
Engineers Gate Manager
New York
-$10.8K -18,630 Closed
Royal Bank of Canada
41
Royal Bank of Canada
Ontario, Canada
-$9K -15,000 Closed
VFA
42
Valeo Financial Advisors
Indiana
-$6.96K -12,000 Closed
TRCT
43
Tower Research Capital (TRC)
New York
-$5.54K -9,554 Closed
HFRG
44
Houlihan Financial Resource Group
Virginia
-$975 -8,000 -40%
Barclays
45
Barclays
United Kingdom
-$865 -7,100 -100%
BNP Paribas Financial Markets
46
BNP Paribas Financial Markets
France
-$703 -1,213 Closed
JP Morgan Chase
47
JP Morgan Chase
New York
-$696 -1,200 Closed
UBS Group
48
UBS Group
Switzerland
-$395 -681 Closed
Osaic Holdings
49
Osaic Holdings
Arizona
-$348 -600 Closed
NA
50
NewEdge Advisors
Louisiana
-$290 -500 Closed

GRTS Hedge Fund Activity: Q4 2024 in Review

6 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in Gritstone bio, Inc. Common Stock (GRTS) for Q4 2024, worth a combined $773 — down 100% from $20.7M a quarter earlier.

Sellers outnumbered buyers: 50 funds closed out of GRTS and 1 opened new positions — a net loss of 49 holders — while 2 trimmed existing stakes and 1 added.

The largest buyer was Baader Bank Aktiengesellschaft, opening a new position worth an estimated $8.19K. The largest seller was Morgan Stanley, exiting entirely with an estimated $5.97M sold.

  • 6 institutional investors held Gritstone bio, Inc. Common Stock (GRTS) as of Q4 2024, down from 56 in Q3 2024.
  • Funds reported $773 of Gritstone bio, Inc. Common Stock stock for Q4 2024, down 100% quarter-over-quarter.
  • 1 fund opened new Gritstone bio, Inc. Common Stock positions in Q4 2024 and 50 closed out, a net change of -49 holders.
  • The largest Gritstone bio, Inc. Common Stock buyer in Q4 2024 was Baader Bank Aktiengesellschaft, an estimated $8.19K added.
  • The largest Gritstone bio, Inc. Common Stock seller in Q4 2024 was Morgan Stanley, an estimated $5.97M sold.

Based on aggregated 13F filings for Q4 2024.